Filing metadata

Accession number
0001127602-21-018535
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jun 01, 2021
Reporting period
May 28, 2021
Description
Insider transaction

Explore SEC Filings Hub